The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...
As pain management makes its own advancements, spine surgeons are putting increased emphasis on multidisciplinary collaborations. Spine surgeons discuss how pain management’s advances are reshaping ...
A Dutch neuromodulation developer has raised $60 million to complete the development of its minimally invasive implant for people suffering from chronic migraines. Salvia BioElectronics’ device is ...
A new wave of innovation may reshape how clinicians approach some of the most persistent challenges in patient care. Non-invasive neuromodulation, a technique that uses gentle electrical stimulation ...
Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...
Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results